eFFECTOR Therapeutics to Participate in Upcoming Investor Conferences

Ads

You May Also Like

Affimed Appoints Dr. Leila Alland as Chief Medical Officer

Heidelberg, Germany, March 19, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical ...

OncoMed Announces Second Quarter 2018 Financial Results and Operational Highlights

-Company prioritizes its navicixizumab resources in platinum-resistant ovarian cancer; prepares to share data in ...